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Agranulocytic Angina for the past seventeen years 
has been highly discussed both in medical centers and 
in literature. During this time the understanding of 
the disease has developed in the curriculum of the 
medical profession. Since 1922, when first described 
as a clinical entity by Schultz, it has been reported 
more frequently as the years passed until at the 
present time agranulocytosis is recognized widely as 
a disease process. 
Just as with the development of any medical 
problem this has been laden with various opinions on 
its course, etiology, etc., all of which has served to 
confuse the searching medical mind as to its true 
standing. At the present time the literature is still 
presenting widely divergent views as to its interre-
lationships. 
Arter a review of the literature, both from a 
clinical and an experimental angle, it has occurred to 
me that many of these rival views are in reality not 
such at all, but merely congruent or parallel facts or 
conclusions which are really more supportive than 
actually contradictory in nature. 
While conducting experimental work in benzol 
1. 
poisoning, an entity which closely simulates granu-
lopenia, my interest in agranulocytic angina was first 
stimulated. The results of these experiments will not 
appear in this paper, but in a later paper. While 
working in this field, I was impressed with the argu-
mentative basis of malignant neutropenia. This thesis 
is an attempt to bring together more closely these 
wandering views and to tie them together more fil'mly 
toward a central thought, that of agranulocytosis itself. 
The following will deal primarily with the clinical side 
of the question, bringing in experimental work only as 
a supportive measure to the clinical case. 
DEFINITION 
Agranulocytosis is a disturbance, constant or intel."-
mittent, chronic or acute, severe or mild, of the hema-
topoietic system, caused by various known or unknown 
factors. Clinically, i.t is more than a disease, fall-
ing more accurately in the classification of a syndrome. 
Characteristically, it incorporates a febrile course 
associated with ulcerative lesions of the mucous 
membranes, especially of the oral cavity, and a complete, 
or almost complete, disappearance of the granulocytin 
element from the circulating or peripheral blood stream. 
Mortality rates in this syndrome are high but are 
2. 
decreasing with the advent of new therapeutic measures. 
Synonyms by which the entity is known are: 
granulocytopenia, granulopenia, agranulocytic angina, 
malignant neutropenia, idiopathic neutropenia and 
pernicious neutropenia. 
HI Br ORY 
The disease, or at least its modern conception, 
was first described by Schultz, a German writer, in 
1922. However, we have the actual condition being 
referred to fi:rty years ago when standard laryngological 
works described the entity under the heading of "putrid 
sore throat" or "gangrenous angina". MacKenzie, in his 
manual of diseases of the throat and nose, credited 
Guber in 1857 and Trousseau in 1865 with having clearly 
distinguished the disease from diphtheria (7). 
MacKenzie and Marrel discussed a condition similar to 
the. modern clinical conception in that they pointed out 
the stomadico-pharyngeal lesions and differentiated this 
condition from other lesions of the same area such as 
diphtheria, scarlet fever, etc. (93). 
In 1902 Brown, although he did not describe the 
case under any of its present nomenclature, reviewed a 
typical case in a debilitated woman following a cervical 
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operation. He found the· typical stomatitis and ulcer-
ative lesions of this region associated with an enlarged 
liver. He reported a low white blood count and a 
differential which showed a complete lack of poly-
morphonuclear-neutrophelic leucocytes. At autopsy en-
larged lymph glands were found in the cervical region. 
Blood specimens taken from various parts of the body 
showed no neutrophils. A bone marrow examination was 
not done. (15) Turk in 1907 reported what appeared to 
be a similar case, but he did not distinguish the 
disease from others. (51). 
Leale described a clinical case in 1910 of a baby, 
age 3i months, with a white count of 3000, mostly 
lymphocytes. In fact, the polymorphonuclear count 
showed these cells to be only one percent. This case 
developed as a periodic fever accompanying furuncles 
and marked prostration. It was recurrent in this manner 
for one year's duration. The child was given immuniz-
ing vaccine which apparently cured him of his malady.(72) 
Cases were described even before this date to quite 
an accurate extent as shown by Senator's article in 1888 
and by Baldridge and Needles' paper in 1902. In 1913 
Larson and Barron reported what seemed to be a typical 
case of agranulocytosis with ulceration of the upper 
jaw. The patient died a septic death. They considered 
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the fusiform bacillus as an etiological factor. This 
was the first mention of the etiology of the disease. 
It is interesting to note that many observers hold this 
to be an etiological factor today, and yet it was sug-
gested before the actual description of the syn.drome.(71) 
It was not until 1922 when Schultz accurately de-
scribed the disease and gave six oases that the attention 
of the medical profession was focused upon this condition. 
The importance of Schultz's observations, outside of 
calling forth attention and accurately recognizing the 
condition, was that he emphasized the fact that the red 
blood cells seemed to be little, if any, affected. (33). 
It is of interest to note that the first case in 
this country was described by Lovett in 1924. He 
pointed out a reduction of white blood cells, chiefly 
of the neutrophilic variety, no anemia, and also a lac k 
of neutrophils in the bone marrow. He accurately de-
scribed the clinical symptoms and signs and stated that 
a cellular reaction to the local pharyngeal lesions was 
lacking. In addition, B.pyocyaneus, having been iso-
lated from the spleen and local lesions, produced a low 
white blood count when injected into guinea pigs. (76). 
Of further historical interest is the development 
of therapy in this field. The use of blood trans-
fusions has long been, recognized as a beneficial and 
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supportive treatment and a possible stimulative element 
in some blood dyscrasias. For these reasons trans-
fusions have been a partial treatment of this disease. 
In late years liver therapy has been inaugurated into 
the therapy. Likewise, X-Ray treatment of the long 
bones has been and is used still as an aid in this con-
dition. Its origin and use is obscure since this is a 
factor Roentgenologists have been taking advantage of 
for years_ in the treatment of certain blood dyscrasias. 
Of more historical interest is the use of nucleic 
acid and its derivatives. This was first advocated by 
Huntley and .Ames in 1897. However, we find that Vaughn 
as early as 1893 suggested nucleic acid as a treatment 
for leucopenia. Since then it has been used quite 
extensively from time to time, mostly upon a theoreti-
cal basis. In 1924 Jackson demonstrated pentnucleotidis 
as being norm.ally present in the blood. Reznikoff in 
1930 used this substance with benef'i,cial results on six 
patients, and Jackson in 1931 said that clinical results 
were gained in 4-5 days, the blood picture being im-
proved in 4-7 days. The excellent work of Doan in 
demonstrating its effect on the blood has proven con-
clusively its beneficial results. (33) 
During the past year a new treatment with yellow 
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bone marrow extract has been subjected which seems to 
give even greater beneficial results. 
Since Schultz's work in 1922 a voluminous amount 
of literature and experimentation has been done which 
seems to be growing with each succeeding year. As this 
is not important historically, the body of this paper 
will deal with the essential points of this material 
as they arise. 
ErIOLOGY 
The factors, both related and direct, which cause 
this disease are represented by a long list reported 
from several investigators. Many of these are the 
results of inductive and deductive logic. Some are 
backed by actual clinical" material while a few have 
scientific experimentation to prove more or less con-
clusively their connection. 
When the condition was first described, the sole 
cause was thought to be the peripheral effect of a 
circulating toxin or toxins of bacteria or else the 
paralytic effect of the same on bone marrow causing 
the hematopoietic tissue to become non-productive. 
This view is still held by some, but many others believe 
that the bacterial infection is only a complication made 
readily accessible by the lowered absolute count of the 
7. 
polym.orphonuclear neutrophilic leucocytes. (65) 
For purposes of discussion the subject may be 
divided into several parts: 
I. Predisposing causes: 
It was at first reported that women between the 
ages of forty and fifty were the ones most likely to 
contract the disease. Figures now show that only 56% 
are female patients, which data seems to rule out the 
predisposing factor of women as contrasted to men. It 
is still most prevalent, however, in middle life. 
The disease primarily affects the white race. 
Another factor is shown in that it has been found to 
arise many times coincident with previous diseases of 
the liver and gall bladder. 
The use of drugs containing the benzene ring, the 
arsenicals, mesothorium, trinitrotoluene, X-Ray, and 
the Gamma rays of radium seem to affect the bone marrow 
in such a way as to simulate this entity ( ?) • 
II. Organisms as a cause: 
The theory of a latent infection, which has been 
present for a long time, is superimposed by a new 
emergency with which the depressed bone marrow is unable 
to cope. 





infection is in the bone marrow or in the blood, or 
both, with the result of a marked leuoopenia. (7). In 
support of this latter view it has been found that 
rabbits in which a hematogenous infection of Talmonella 
surpestifer has been produced often show agranulocytosis. 
This is accompanied by intense necrosis of the bone 
marrow without signs of regeneration.(26) 
Other organisms have been isolated from the blood 
stream in this condition. These are usually the organ-
isms of the mouth such as Streptococci hemolyticus and 
viridans, various Staphylococci, etc. The most constant 
offender found in the blood stream in this disease is 
Vincents' organism. (66). 
Linthicum produced the disease in 1927 by inject-
ing B.pyocyaneus, isolated from the throat of a woman 
suffering from granulopenia, into a guinea pig which 
resulted in a lowered white blood count. (75) However, 
Kracke demonstrated that in a large list of clinical 
and experimental cases the pathology was always first 
noted in the bone marrow. This was followed by a low 
white count. The infection was always a complication 




III. Septic and Toxic Processes: 
Stocke believes that neutropenia is not a special 
disease but an abnormal reaction to sepsis. In contra-
diction to this view Zadek believes that a virus or 
bacterial-toxin of sufficient potency to destroy the 
granulopoietic tissue so completely would not spare so 
uniformly the closely related contiguous cells. (7) 
Stocke's explanation is regarded by many investi-
gators as a very plausible one. Many typical cases 
show a localized mouth infection and suggest a virulent 
circulating toxin which destroys the leucocytes of the 
blood and bone marrow. (62) Roberts and Kracke were 
unable to demonstrate any circulating agent which would 
affect the blood cells. After mixing normal blood with 
the serum of a diseased patient, they found no change 
in the cells after various periods of incubation. (105) 
Blumer, however, reported a case in which agranu-
locytosis developed after sepsis was present. (12) 
The whole problem of bacterial toxins as an entity 
in the production seems to be highly disputed. One 
investigator claims to have produced granulocytopenia 
by porous bags transplanted within the abdominal cavity. 
In these the bacterial culture was placed. The toxin 
could diffuse out, but the bacteria could not. Injections 
of the same bacteria would not cause granulopenia but 
10. 
rather a typical septic rise in the white blood picture. 
No one has been able to reproduce his results. 
IV. Hyperergic Inflammation. 
Schilling believes that the phenomenon may be caused 
by a form of allergy in which the bone marrow is the 
point of least resistance. As a partial support of this 
view, Bromberg, Murphy and Kracke have observed the con-
dition a:rter prophylactic injection of typhoid toxoid (?). 
Patch tests on persons who have been suspected of having 
amidopyrine as the etiological factor sometimes shows 
an hypersensitivity with the same drug. (39). 
V. Congenital and Familial Anomaly: 
Hart, a:rter observing malignant neutropenia in 
two sisters, suggested familial tendency. On the other 
hand, Wolf suggested a familial weak hemopoietic system 
when he observed a brother and sister, one with neutro-
penia and the other with myeloblastic leukemia. This 
latter view is held by Bickel (7). 
VI. Chemical Poisoning. 
This includes the entire class of drugs which may 
serve to weaken the hemopoietic tissue. Many do not 
produce a true agranulocytosis. For example, benzene 
usually does not produce a typical benign or malignant 
11. 
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neutropenia but rather a depression of all the bone 
marrow elements; so.that anemia, purpura, and sometimes 
methemoglobemia as well as leucopenia and neutropenia 
are produced.(?). Many others have been reported such 
as arsphenamine by Talley and Griffith, Kastlin, and 
others; gold preparations by Jacob and Dowody; arsenic 
by Dodd and Wilkinson, Wheelihan and Farley; mustard 
gas by Krum.bhaar; and sulphanilam.ide recently by McGuire 
and others. Later, this list of drugs together with 
others producing agranulocytosis will be considered 
more thoroughly. 
VII. Endogenous Disturbances; Production of Chemotactic 
and Maturation Factors. 
It is known that two different processes are 
necessary to maintain production and amount of granu-
locytes in the circulation: (1) maturation, and (2) 
delivery to circulation. Animal experimentation, there-
fore, might be carried on by removing different glands 
of internal secretion. This might reveal valuable infor-
mation concerning etiology and treatment.(?). For 
example, Richardson in 1933 reported agranulocytosis as 
being present in one of his patients who had Carcinoma 
of the Pancreas. He believe that this might be caused 
by toxins liberated from the growth ( 104). 
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Some investigators have advanced the theory that 
toxins from bacteria might act in such a way as to 
paralyze the stimulating endocrines which stimulate the 
bone marrow either for maturation or delivery to the 
peripheral blood channels. (5). 
Other endocrine disturbances of marrow function 
have been noted. Hubble reported bone marrow depression 
accompanying pituitary basophilic insufficiency. Button 
and Corey produced neutro})enia with adrenal insufficiency 
with a subsequent return to normal when the animal was 
fed cortico-adrenal extract. In thyroidectomized 
rabbits there ensued an aplastic anemia according to 
Kuncle et al (64). 
Another important etiological agent is radiation. 
X-Ray in small doses tends to stimulate the hemopoietic 
centers but in moderate a.nd large doses tends to destroy 
the genninal blood cells. Radium, thorium, X-Ray, and 
other radiating materials have a like effect. In 
supporting this belief Kracke stated that the disease 
is predominantly one of the white race, negroes being 
little affected. "Perhaps", he states, "it is due to 
the greater susceptability of the white skin to radi-
ations from the sun". This investigator was firmly 
convinced that most cases show a history of some chemical 
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toxin, or X-Ray, etc. He advanced some interesting 
statistics to hold forth his belief. 
The disease has been high in incidence in both the 
United States and Germany where these drugs are sold 
most frequently. On the other hand, countries which do 
not vend these drugs to a very great extent have a low 
incidence. Also it is a disease of the "better class". 
And finally it is found most pronounced in the medical 
and associated professions, for here are the greatest 
offenders, if such be the case, of the consumption of 
products of the benzene ring. There are fifty times as 
many physicians as lawyers and one hundred times as many 
nurses as ·female teachers who suffer from the malady (64). 
Other factors of etiologic importance have been. 
listed: (a) Menstruation: Cases of women who have 
periodic attacks every twenty-eight days have been 
reported; (b) Fatigue: Many cases which give a history 
of restlessness, overwork, sleeplessness, or work. (18); 
(c) Pregnancy has been observed as a possible precursor 
of the disease. (66). 
Aside from all these etiological factors of known 
or surmised value, there are found many cases of obscure 
origin. These are the so-called idiopathic agranu-
locytoses. Why? Is there an increased peripheral 
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destruction, an abnormal distribution, or a failure of 
cell development? There is no evidence of increased 
peripheral destruction. The spleen is a little enlarged 
and the red cells are not disturbed. Likewise, there 
is no evidence of abnormal distribution of cells. 
Kracke in checking blood counts distributed over 
the entire body, both in venous and capillary systems, 
finds no striking deviation from Garrey's work, which 
shows a norm.al shi~ in the count in various places at 
various times. It is plain that a developmental cause 
is present many times since autopsy reports and sternal 
punctures show this to be true. Roberts shows that the 
sequence of events is bone marrow hyperplasia followed 
in four days by peripheral effect which is then super-
imposed by the clinical picture in about three or four 
days. This has been confirmed by many investigators.(105) 
Is it, then, an entity, a deficient res~onse of 
the patient, or a non-specific reaction to a factor of 
unusual absolute or relative virulence. The theory 
that bacteremia always precedes agranulocytosis has been 
disproved. That it is not always a bone-marrow 
hypoplasia is seen by patients who ~how a normal appear-
ing marrow with a peripheral agranulocytosis. Perhaps 
a chemotactic as well as a maturation factor is present. 
15. 
Perhaps anaphylax,is is more important than is supposed. 
Why should a person have a sudden leucopenia a few hours 
after taking a drug if he is not hypersensitive to this 
chemical so as to have "bone marrow shock" due to a 
sudden idiosyncrasy? (39). 
It is seen, then, that although several etiological 
factors are of great importance, many are only theo-
retical and many more are entirely unknown. Perhaps 
the variations of individuals are being overlooked too 
much in this field. Some people may be born with weak 
or sensitive marrow just as other people may inherit 
other deficient functioning organs. Would this not 
explain many of the idiopathic cases? Beck believes 
the primary pathology to be not in the bone marrow but 
in the particular organ or tissue that regulates granu-
lopoiesis. Those with a normal bone marrow lack 
chemotactic factors while damaged bone marrow shows a 
lack of maturation factors. 
CLASSIFICATION 
Several classifications have been advanced for 
the purpose of clearly defining the various types of 
agranulocytosis into a workable diagnostic pattern 
either from a clinical or a pathological point of view. 
16. 
!""'-
From the standpoint of a more thorough understanding of 
the disease, two classifications are necessary; one from 
an etiological angle and one from a clinical view point 
as far as the resultant symptoms are concerned. Inasmuch 
as this is a paper of primarily clinical aspects, the 
subject will be most thoroughly proposed without un-
necessarily cluttering the field with detailed 
pathological classifications. 
An etiological classification: 
1. Agranulotoxicosis 
{a) Caused by such myelotoxins as benzoe, arsenic 
and the benzene derivatives. 
2. Agranuloradiations 
(a) Caused by such elements as X-Ray, Thorium.-X, 
and Radium. Usually involves erythropoiesis 
as well as granulopoiesis. 
3. Agranulosepsis 
(a) Caused by bacteria or their toxins. 
4. Agranulocytosis 
(a) Of unknown origin, consisting of depression of 
bone marrow and subsequent overwhelming of body 
in areas by bacterial invasion. 
{b) Of unknown origin, with the usual depression 
of bone marrow and peripheral blood granu-
locyt es, but without sepsis. 
l?. 
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( c) Peripheral granulocytopenia without a depressed 
marrow. 
5. A leukemic lymphatic leukemia 
Granulocytes disappear from peripheral blood. 
6. Acute infectious diseases 
Examples: mumps, measles, malaria, influenza, 
dengue, tuberculosis and lues. 
7. Roseola Infantum 
A neutropenice of infancy. (105) 
On the other hand, there should also be a classifi-
cation which presents the clinical picture: 
1. Acute agranulocytosis with or without sepsis. 
Most common form, sepsis, may complicate, but 
the patient may die from prostration before 
inauguration of sepsis. 
2. Acute Recurring Agranulocytosis with or without 
resulting sepsis. 
(a) Differs from acute agranulocytosis in having 
two, three or more remissions. 
3. Acute agranulocytosis of unknown cause. 
4. Chronic agranulocytosis of unknown cause. 
Another clinical classification which is perhaps 




{a) Characterized by chill, high fever, necrotiz-
ing angina, occasional jaundice, and 
album.inuria, extreme leucopenia, and neutro-
penia. This usually involves necrosis of 
granulopoietic system and is generally fatal. 
2. Sub-acute, prolonged:-
3. 
(a) Tender enlargement of lymph nodes and spleen; 
moderate to extreme leucopenia with reduction 
of polymorphonuclear neutrophiles. 
(b) Usually reddened tender pharynx toward end of 
course. 
( c) Of one to three weeks duration usually with 
recovery. 
Recurring or relapsing type. 
(a) Three or more attacks, weeks to months apart. 
Symptoms similar to either of other two above 
types. 
4. Subchronic type. 
(a) Leucopenia less intense. 
(b) Bone marrow shows more active regeneration. 
(c) Usually of one year or more duration with 
recovery. 
5. Cyclic type. 
(a) Regular, recurring, periodic neutropenia. 
These then furnish the reader with a fairly accurate 
classification for clinical reasoning. 
19. 
. SYMPTOMS .AND COURSE 
In considering this phase of the subject, the 
discussion will be divided into five parts, namely; 
agranulotoxicosis, dealing with the chemical etiological 
factors; agranuloradiation, dealing with X-ray, etc.; 
agranulosepic, dealing'with bacteria and their products 
as etiology idiopathic agranulocytosis; and finally, 
miscellaneous causes either proven or suspected. Because 
it is the most true clinical type and the first de-
scribed, the general classification will be based about 
agranulocytosis proper; the following four types will 
be described only inasmuch as their variations. 
Agranulocytosis: 
This disease cannot be a specific disease process 
and entity because: (a) there is a marked leucopenia 
in several types of infection; (b) there are a variety 
of necrotic foci; (c) epidemicity has not been reported; 
(d) it is not confined to class, age, sex etc.; (e) there 
is no constant etiological factor; ( f) it has not been 
satisfactorily reproduced experimentally. ( 50). 
The patient presents himself in a very pathetic 
state. He is wilted in appearance and his skin shows 
marked palor although the mucous membranes are of 
surprisiµgly good color. He is weak, sometimes almost 
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to the point of prostration, with a general toxic 
appearance. Jaundice is sometimes but rather rarely 
seen in this condition. The liver and spleen may be 
enlarged. He complains of easy fatigue and a constant 
drowsiness. He may also state that he seems to be easily 
infected with various organisms. 
The severity of these symptoms is usually parallel 
to the degree of leukopenia. This is the condition and 
stage in which the physician usually sees the patient. 
It has been presented first in order that the idea might 
be gained as to the probable condition of the patient 
when diagnosis is made. (?) 
The onset usually occurs in a period of seemingly, 
good health, but may follow various chronic conditions. 
It is manifested by a sudden rise in temperature, sore 
throat, chills and malaise, and perhaps dysphagia, 
vomiting, headache, and general aching. A fetid odor 
of the breath is almost always present. The fever is 
from 101' to 106', and of continual type. ( 61) 
The previous health may be characterized by lack 
of vitality and by weakness, but this is usually not 
true. The patient may also complain of palpitation of 
the heart and a murmur may be present. (?) 
21. 
At this time an examination of the blood will show 
a lowered white blood count with a preponderance of the 
lymphocytes and a lowered polymorphonuclear count. 
Platelets are usually within normal limits, but in some 
types may be reduced. This will be discussed later. (37} 
Coincident with or just following this period, 
ulcers of the gums, so~ palate, uvula, pharynx or 
other oral locations usually develop. This is usually 
accompanied by marked edena of the surrounding tissue 
and a regional lymphadenopathy. A superimposed picture 
of sepsis is now present. A membrane, yellowish or 
green in color, forms over the ulcers which may be 
pulled free rather easily with no evidence of bleeding. 
These ulcers may be present on other mucous membrane 
surfaces such as the anus and vagina, but this is not 
constant. ( 89) 
According to Kracke, the blood picture always 
precedes the clinical onset, but Green and Fitz-Hugh in 
1933 state that it sometimes follows sepsis. (66) (37) 
Many of these cases die with bronchial pneumonia. ( 66) 
· Most of the above described cases which are the 
typical acute variety may die, but some may recover to 
become chronic. In this type· an acute future remission 
usually occurs. In another type the patient may 
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completely recover only to suffer another attack at a 
later date. According to its regularity or non-
regularity, this would either be the cyclic or remitting 
type. In these types the blood count never returns to 
normal as far as the neutrophilic elements are concerned 
but always remains at a low normal. 
In the chronic type with no acute attacks, the 
observer usually sees a constantly low (from 1,000 -
3,000) white blood count with a lowered neutrophilic 
element. The only constant symptom is weakness which 
is accentuated when the blood count drops. (66) In these 
long continued cases one usually sees monocytes and 
endotheliocytes in the peripheral blood. This is 
probably due to an extramedullary response. ( 42) 
To bear out the above points, a few clinical cases 
might be reviewed briefly. 
La Salle reports a case with the typical picture 
of an acute type of particular violence. Patient had 
been feeling ill for a few days ~~th symptoms of weakness. 
One day he developed a headache. Upon the following 
day he was very weak with a sore throat; he stayed in 
bed with a cough. A physician was called who diagnosed 
the condition, Influenza. Two days later he was 
ad..rn.itted to hospital in a comatose cond.ition. His 
. 3. 
throat was very red and his pulse rapid with a low 
blood pressure; respirations were 32 per minute. 
A red blood count showed 4,300,000; there was a white 
blood count of 4,300 with 2% neutrophiles. The patient 
died seven and one-half hours later. {77) 
Another case reported with fever, sore throat, 
malaise and prostration. The blood count was low on 
the white side with a low percentage of neutrophils. 
Treatment was of no benefit; the patient's condition 
became worse, his throat ulcerated and he died without 
sepsis. ( 103) 
A case showed a white blood count of 3,500 six 
weeks before his death. He entered with sore throat, 
ulceration, lymph adenopathy, weakness, drowsiness, 
malaise. The white blood count was 160, polys 22%. 
The case progressed rapidly and resulted in death. (4) 
Another case reported an anal swelling five weeks 
before, acute pain in the same region three weeks before, 
bleeding from anus and malaise. Patient was operated 
for hemorrhoids and an anal fistula noted. Directly 
afterwards he developed an anal ulcer. The white blood 
count was lowered to 1,700, predominantly lymphocytes. 
Clinically he showed malaise, fever, etc. His white 
count went steadily downward until he died. (17) 
24. 
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Another case with the same typical findings, except 
an additional skin necrosis was noted with an accompany-
ing pharyngeal ulcer. Another case showed circumscribed 
ulcers on legs accompanying gum ulcers. In the latter 
case, although the platelets were decreased, no bleeding 
was noted. (21) 
Marriott reports a typical case with a white blood 
count of 900, although the red count remained normal. 
The case recovered. Cannon reports a case with a white 
blood count of .400 that recovered. (80) (19) 
When we come to the remission type of this entity 
we usually have a slightly less acute form, separated 
by periods of good health. 
A case has been reported in which a patient suffered 
sore mouth, fever, malaise, drowsiness, but of a less 
acute form and was able to walk about. His red blood 
count was little affected and although his platelets 
were decreased, he suffered no hemorrhage. His white 
blood count was lowered and his neutrophils were 
reduced. Between attacks· he was able to carry on his 
activities in good health. Patient is 19 years old 
ana still having his attacks. (108) 
A case vdlich had three relapses, each having the 
typical acute symptoms and signs, although treated with 
X- Ray. died. (42) 
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Chronic cases present same symptoms with no 
ulcers or extreme prostration. The blood count is 
usually higher and the percentage of neutrophils 
generally greater. Patients have weakness in proportion 
to the low white blood count. 
Kracke et al, believes that infection actually 
stimulates the bone marrow, thus shortening the course 
of the disease. They believe that infection may weaken 
and serve to bring on second attacks, which may be 
accompanied by nervous symptoms. ( 65) 
The next class to be dealt with is agranulosepsis. 
Du Bray reports a very typically acute picture of 
this disease that had recurring attacks every few months 
for a duration of two years. The patient died in an 
acute attack. The throat was continually positive for 
Loefflers bacillus, and he offers the possibility of a 
bacterial, bodily balance which would shift one way and 
then the other. (33). 
Another case was that of a woman who had Herpes 
zoster with recovery. After this she developed a 
coronary occlusion with apparent definite improvement. 
Later, a pulmonary infarct was contracted. She was 
progressing quite well following this when five days 
later, she had a temperature of 100.4. She had both a 
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sore rectum and a sore throat. The next day her 
temperature went up to 105°. Her throat was very 
reddened and her blood picture showed a white blood 
count of 1200; 100% of which were lymphocytes. One 
injection of neoarsphenamine was given. Her temperature 
decreased, but the next day was again up to 105°. Her 
white blood picture showed 550 cells, all lymphocytes. 
She died shortly afterwards. (3). 
Blumer describes a case with a tooth absoess that 
developed a weakness, cough, anorexia, fever, loss of 
weight and an enlarged liver. The blood picture showed 
a marked leucopenia and anemia. Death was due to sepsis 
and lobar pneumonia. The bone marrow showed strangely 
mark'ed hyperplasia. 
Swartz described a case with perinephritic abscess 
who recovered, developed gingiv:tti.s and died with typical 
agranulocytosis. 
Strusberg describes a case following osteomyelitis 
which again showed the typical picture. (12} 
Three cases were ·reported by Hard, including two 
sisters and one sister-in-law. All were typical cases. 
All showed a positive blood culture of Friedlanders 
pneumobacillus. Hard believes these cases were on an 
infectious basis, the location in the blood stream. (4?) 
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Huncler pointed out a case following fracture of the 
tibia, cellulitis and erythema multifo:rme. (52) 
An interesting case was published by Dwyer who 
described a boy, age six, with anemia, enlargement of 
salivary glands and spleen. He developed a leukopenia 
with complete absence of neutrophils. There was no 
extreme lymphocytic nor myeloid infiltration of organs 
as appear in leukemia. There was no evidence of primary 
disturbance of myelogenous marrow at autopsy. A 
streptococcus septicemia was found to be present at 
necropsy, which pointed to the infectious agranu-
locytosis. (34). 
Rutledge et al, cite a case of a 2t year old child 
who had attacks of furunculosis every two to three 
weeks for six to ten days. These "attacks" had been 
present from early childhood and were accompanied by 
gastro-intestinal disturbance, lassitude, drowsiness, 
irritability, sore throat, sore mouth, cervical adenitis, 
fever of septic type, leucopenia agranulocytosis. 
Patient would be ill for four to six days, then 
mononucleus and transitional cells would appear and the 
case would improve. (108) 
Babbit reported a case under his observation for 
some period, who developed a sore mouth from which 
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Vincent's was cultured; subsequently she developed a 
typical agranulocytosis. The patient recovered under 
local treatment supported with blood transfusions and 
X-ray of the long bones. (5). 
A case cited where a combination of Streptococcus 
and Staphylococcus septicemia, together with Vincent's, 
seemed to cause the typcial picture of granulopenia. (4?). 
All these case reports seem to point out that 
agranulocytosis may be etiologically produced by 
infection. The cases were briefly stated and in general 
showed the typical picture with one of sepsis imposed, 
i.e. septic temperature, etc. 
On the other hand, some investigators as Hueper, 
O'Connor and Kracke, believe that the infection is 
secondary to the lowered blood count. In reviewing 
their cases, they have been able to prove this in most 
of them and never have showed the reciprocal to be true. 
Probably both happen, since one investigator was able 
to produce the picture with bacterial toxins but was 
unable to produce the symptoms with the bacterial 
cultures. It seemed from this that probable toxic 
etiology was an established fact, but that bacteria 
themselves seemed to raise the blood count, as is 
generally suspected, and not lower it. (28). 
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Agranuloradiation has been described as another 
type of the entity. 
Although radiation is used as a stimulant to the 
bone marrow in the form of X-ray, it is not without 
its dangers. A dose of the radiation Which would 
stimulate one person's marrow to hyperplasia, might 
definitely impede another. The exact dosage is, 
therefore, uncertain and only very small doses should 
be given at the beginning of treatment and these only 
by a competent radiologist. 
In the same manner doses of radioactive substances 
as radium and thorium act. Thorium used in stimulating 
doses causes first an anemia and brief leucopenia which 
is followed by a lymphocytosis and a polynucleosis. 
The platelet count is reduced and a delay in bleeding 
time with poor clot retraction is present a~er two days 
of 5cc injections (2 injections). If the dosage is 
kept up, a gradual depletion or a complete aplasia of 
all elements of the blood is not ed. (113) 
Often radioactive substances are deposited in the 
spleen, bone marrow and liver from small continuous 
doses. In these cases the first effect is a stimulatory 
effect on all blood elements which continues until the 
blastic cells are irritated too long; then we get 
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destruction and the resulting aplastic anemia. 
Thorium and mesothorium and radiothorium are more 
active than radium in this manner. 
One employee, working from five to six years, 
may ea~ily have one mg. of radioactive substance 
deposited in bone, allowing a liberal amount as 
'excreted. Such a case was admitted to a hospital with 
a temperature of 101°- 102° and a pulse of 120/ minute. 
His gums contained ulcers. The laboratory work showed 
hemoglobin 33%, red blood count 1,400,000 and white 
blood count of 400 with 40% neutrophils, 2% histeocytes 
and 58% lymphocytes. There were areas of hemorrhage 
and petechial about the body. The bone marrow was deep 
red, resembling pernicious anemia, except that there 
were no iron deposits (hemosiderin) and no destruction 
of red cells. The spleen showed atrophic malphegian 
corpuscles and diffuse fibrosis. The peripheral blood 
was that or a profound anemia with anisocytosis, 
megaloblasts, and a leucopenia. Electrometer tests 
were positive. The patient ,died. (81). 
The reticular endothelial cells of the liver and 
spleen show cloudy swelling and macrophages are present.(113) 
In this form of poisoning, then, we do not see a 
strict agranulocytosis, but rather an associated 
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agranulocytosis with accompanying anemia and reduction 
of other cellular elements including thrombocytes. 
Since the granulocytes are affected first, a disease 
process resembling agranulocytosis is obtained. 
Agranulotoxicoses forms that group of clinical 
granulopenias whose etiology is benzol and its deriva-
tives mainly. 
Many chemicals which are by some generally thought 
to produce this entity are innocent of it. It would be 
well to consider these briefly. 
Lead is considered sometimes to be a leucotoxin, 
but only affects the red blood count. 
Cases reported preceded by arsenic ingestion, but 
experimentally a great majority of clinical cases again 
show only erythropoiesis to be affected. 
Mercury is primarily an effector of red blood cells 
as is vanadium. Phosgene increases leucocytes and 
neutrophiles but later a reduction of red cells, 
hemoglobin results. Hydrogen sulphide stimulates 
lymphocytes, also the polymorphic elements. 
Of course, if one believes in the monophylitic 
theory of blood production, it is easy to see how a 
primary erythropoietic toxin might in time become a 
leucocytic toxin by destroying the stem cells of both 
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white and red elements. Likewise, any substance which 
stimulates leucoyy'ti'C stem cells may, if' continued long 
enough or in high enough doses, injure the cells; so the 
clinical reported cases with these substances may be 
authentic even if' only one is reported. 
The most important chemical poisons to the leucocytic 
system are, benzene and its derivatives. Benzene in 
industry is a frequent offend.er. The symptoms are 
ushered in by dizziness, incoordinated movements and 
twitching of' muscles which may last for hours. Bright 
red spots of petechial hemorrhage appear on the body; 
cynosis is prevalent and there may be massive hemorrhage 
from the gastro-intestinal tract. A marked weight loss 
is generally noted. A hemic murmur may be present. No 
benzene can be demonstrated in the blood, but the phenols 
in the blood and urine increase in concentration. Tne 
blood picture shows a leucopenia, a reduced hemoglobin, 
an anemia and· a thrombopenia. The red cells show 
anisocytosis and poikilocytosis. The neutrophils are 
reduced, and the mononuclear cells are elevated. There 
may be a complete absence of white blood corpuscles. 
A strange factor enters when one finds that recovery is 
possible even after almost total aplasia of the bone 
marrow. ( 45) 
33. 
Amidopyrine usually, if taken in large enough 
doses, produces the same results. Trinitrololuene 
produces the same results as do other benzene derivatives. 
It has been shown experimentally that benzene is 
primarily a leucotoxin. Most observers think even more 
specifically and designate the neutrophiles. Thus 
clinically many of the benzene derivatives may cause 
almost typical agranulocytic angina. A few clinical 
cases might be briefly mentioned. 
Kracke mentioned a case that took several benzene 
derivatives for three years before an attack of agranu-
locytic angina. The attack was accompanied by 
methem.oglobinemia which further points to the etiology 
of benzene. (67). 
One patient took over ten gallons of elixir of 
phenobarbital in five years together with luminol, gr~ 
when she woke up at night. She developed a severe anemia, 
a white blood picture of 1, 500 with a low neutrophile 
percent. Although these never completely disappeared, 
the patient recovered. ( 54) 
Another patient was a heavy user of aspirin for 
several years. This person showed a typical agranu-
locytosis with a low white blood count (470), with low 
percentage of neutrophiles. The patient recovered from 
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this attack but later died in a second attack after 
extraction of some teeth. (86). 
Berg and Holtzman report a case that took 5 gr. 
of amidopyrine every 4 hours for five days and developed 
fever, cramps and nausea. The medicine was discontinued 
for four days and the symptoms were alleviated. Then 
she took one tablet after meals f.or seven days and the 
symptoms returned. After she again felt well, two tablets 
a day were taken for eleven days following which nausea, 
vomiting, fever of 104°, prostration and abdominal pain 
developed. The next morning the temperature was 107°; 
a marked leucopenia was noted in which no neutrophils 
were seen. The larynx becameedematous and a~er three 
days, ulcers of pharynx developed. The patient died. (11). 
A patient entered a. hospital with a history of 
ingestion of three tablets of Causalin (equal parts 
hydroquinoline and.amidopyrine) a day for one month. 
A week before, a sore throat and a fever developed. 
She had a white blood picture of 1,200 of which only 
4% were neutrophiles; the red blood p·icture was also 
reduoed to 3,300,000~ The patient died. 
Another patient took 200 tablets of the same drug 
in three weeks. On the eleventh day she developed ulcer 
of the tongue, chills and a fever. At the end of three 
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weeks her white blood picture showed 1,600, 63% 
lymphocytes, 35% monocytes, 2% basophiles and no 
neutrophiles. The red blood count was reduced to 
3,830,000 and 
The patient recovered. (55). 
Fitz-Hugh states that am.idopyrine is an important 
factor but will not cause agranulocytosis by itself, 
as it needs an idiosyncrasy to enhance its action. 
There is no way of telling which patient will show this 
idiosyncrasy. Patch tests frequently show sensitivity 
to am.idopyrine. Once established, the patient usually 
dies with this poisoning. (39). 
Sulphanilamide was given to an old syphilitic 
patient, 5 gr. for two days, 3.75 grs. for three days, 
2 grs for 13 days. On the fifteenth day, the white blood 
picture was 3, 900, tb.e red blood count was 4, 170, 000. 
After eighteen days, the white blood picture showed 
2,000 cells., 100% lymphocytes. A high fever and a sore 
throat developed. The patient died. Edema of larynx, 
edema of Kupfercells of liver, atrophy of splenic 
malphigian bodies, marrow depleted of polys, stem cell 
hyperplasia and reduction, degeneration of nucleated 
reds were seen at autopsy. (109). 
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Another patient received 110 gr. of sulphanilamide 
in treatment of a Bartholine abscess. He received in 
seventeen days, two 15 gr. doses, and after first dose 
felt dizzy, drowsy, headache, nauseated and his heart 
showed palpitation. The white blood picture showed 
1?, 500, 8?% of which were polys. The red count was 
normal. Two more days passed in which 80 grs. of drug 
were given. The red blood count dropped to 3,960,000 
and the white blood count to 2,900 with 64% neutrophiles. 
Nine days later no neutrophils in blood. The drug was 
stopped and the patient returned to normal. (1) 
Sulphanilamide was given to another patient at the 
rate of 15 grs. per day for thirty days. The patient 
developed typical neutropenia with white blood count of 
450 and no neutrophiles. A~er ceasing the drug, the 
patient recovered. Sulphanilamide at ?i grs. per day was 
given with a rapid fall in white blood picture and 
neutrophiles being noted. (8?). 
Neoarsphenamin upon its first dose caused fever 
and chills in a patient. After one year's treatment it 
caused nausea, vomiting a.~d pain in abdomen of three 
weeks duration. Later bismuth and neoarsphenamin were 
continued. Forty eight hours after the last injection 
chills, fever, malaise were noted. Platelets count was 
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84,000; the white blood picture showed 2,000 with 
1/3-1/2 of them neutrophils. The patient recovered in 
four days after stopping the treatment. (10). 
A case showed typical agranulocytosis. After two 
weeks treatment with silver salvarsan, the patient 
recovered after cessation of treatment. (82). 
Thus it seems that both benzene and its derivatives 
react the same or practically the same on man. 
A few other myelotoxins may be mentioned briefly 
by citing a few cases as examples. Two doses of sodium 
theosulphate of 40 mg. in injections were given one week 
apart. A night following the second dose the patient 
developed a typical agranulocytic angina as far as the 
blood picture was concerned. The next day clinical 
symptoms were ushered in. The patient recovered with K 96 
treatment in ten days. ( 101). 
In a case of cerebral injury, potassium. arsenite 
was given for 36 days, starting at 6 minims and building 
dose to 39 minims daily. Phenobarbi tol was given at the 
rate of gr.1;s per day. The white blood picture decreased 
from 14,000 to 1,300 with a decrease in neutrophiles from 
62 to ~. Recovery followed in two weeks after cessation 
of treatment. ( 125) 
Another case (developed after a case of mercurial 
injection) which was quite typical except for a profound 
anemia, and· thrombocytopenia with purpura. Typical 
agranulocytic symptoms prevailed, since the anemia 
secondary to thrombopenia, as shown by marrow which was 
aplastic for granulocytic elements but hyperplastic for 
erythrocytic elements. The case died. {35). 
Thus it is seen that the chemical myelotoxins do 
not strictly hold to the granulocytes, but can and 
usually do, incorporate destruction of other blood 
elements with the production of the symptoms typical of 
depletion of these same elements. 
Miscellaneous types:--
In other blood dyscrasias such as lymphatic leukemias, 
etc., the myelogenous elements may be "crowded out"; 
so that neutrophiles are not developed or are greatly 
in minority. Symptoms of agranulocytic angina usually 
are superimposed by the symptoms of the other disease.(27) 
Added insulting of the system with bacterial or 
other toxins may produce the typical picture. Cases of 
carcinoma and other debilitating diseases have been 
complicated with this picture of agranulocytic angina, 
probably also from toxic effects on bone marrow of the 
luberated toxins. 
Call reports a case of an eight months pregnant 




rigors, laryngitis, throat ulcers and a temperature. 
The white blood picture was low, with a low percentage 
of neutrophils and a low red blood picture. The mucous 
membrane of the rectum, vagina and vulva was swollen and 
red. Typical agranulocytosis resulted. (18). 
Other etiological factors such as fatigue, sleep-
lessness, worry, etc., are accredited with causing the 
typical picture. 
It is seen, then, that regardless whether or not 
the etiological agent is known, the basic synchrone is 
very similar. 
As additional elements, variations such as anemic 
symptoms of benzol poisoning or the hemorrhage signs of 
the same or the septic symptoms of agranulosepsis may 
occur. 
"EXPERIMENT AL WORK 
This section will not be inclusive of this work, 
but will only deal with that portion of clinical 
experimental work or animal experimentation which directly 
bears out some clinical point or seems to disprove some 
clinical conception which ha~ been mentioned in previous 
· sections of this thesis. The animal experimental points 
therefore, will be mentioned very briefly since this is 
primarily a clinical thesis. 
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Dr. Plum had treated a patient with 20 grains of 
amidopyrine (who had suffered from agranulocytosis several 
years previously). The patient developed chills and fever 
and was indisposed one hour after injection. His 
sedimintation rate decreased in five days from 28 mm. 
) 
per hour to 10 mm. 
The white blood picture dropped from 9,000 to 
1,500 in one hour and one half. In double that time 
it had climbed to 11,500, then slowly down to 2,000 in 
24 hours. It then climbed to 10,400 in eight days and 
leveled off gradually. Granulocytes dropped from 5,700 
to 1,450 in one and one half hours. Twenty four hours 
later the count decreased to 1,150 and remained in this 
neighborhood for ten days, after which it returned to 
normal. There was a marked shift to the left in these 
elements; the non-granular elements had a primary fall 
in the first hour to 150, then gradually climbed to 
normal in ten days. (95). 
From this it may be seen that drugs undoubtedly do 
produce the entity, and also that the more primitive 
cells, the lymphocytes, are greatly affected. Since 
here is a disturbance of potential stem cells, one may 
gather how serious and persistant the leucopenia may 
become. 
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Harris and Schattenberg extracted the toxins 
from cultures of bacteria which were isolated from 
stools of a~ agranulocytic patient. Animals injected 
with this toxin produced a low white blood count, 
predominately of a lowered neutrophil type. Injections 
of bacterial cultures showed a raised count. Different 
organisms producing this effect were B. enteritidis, 
Streptococcus, hemolyticus, staphlococcus aureus, B. 
typhosis, and B. welchii. (46} 
In another experiment, bacteria from focal infections 
of patients were cultured. These cultures, mostly 
Staphlococci and ~treptococci were inplanted intra-
peritoneally. They produced a leucopenia, some acute, 
but only the granulopoietic elements were affected, the 
mononuclears remaining constant. Controls were negativ~. 
Cultures injected caused a leucocytosis. 
These experiments showed that toxic products of 
bacteria may have a similar effect, but that bacteria 
themselves do not. (28). 
Benzol experiments in general bear out clinical 
experiments in that an agranulocytosis is produced and 
also a depletion of red elements; occasionally various 
other or all of the other elements may be depressed such 
as: the thrombocytes, lymphocytes, etc. Many clinical 
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symptoms may also be noted in these animals such as 
loss of weight, malaise, anorexia, oral ulcers, bone 
marrow, spleen and lymphatic tissue changes, etc. 
The same can be said in general for the products of 
benzene, amidopyrine, acetaphede, trinitrololuene, and 
other benzene ring products. Perhaps it is of interest 
that benzol products with an amino group attached to 
the ring seem more o~en offenders than those that are 
not. Selling explains this by saying that these are the 
ones most easily oxidized to toxic products such as 
phenol and catechol, etc. He attempts to prove this by 
showing increased excretion of phenol a~er benzene and 
an increased amount of phenol in body tissues. Nowhere 
could he demonstrate benzene, except at site of injection. 
This clinical paper is not to be laden with further 
indirect experimental evidence, since it can never be 
directly applied to the clinical case, but will refer 
the reader to articles of this nature, should he desire 
to acquaint himself with this part of the work. (110), 
(118), (113), (82), (78), {102), (13), (97), (23), (53) 
( 91) , ( 20) ' ( 120) ' ( 121) , ( 12 2) ' ( 12 3) ' ( 124) • 
PATHOLOGICAL .ANATOMY 
In writing the section on pathology, it is well to 
oover a few physiological points and to deal with the 
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pathological state more as a physiological mechanism 
since it is only in this manner that effects can be 
visualized. 
The granulopoietic system is located in the red 
bone marrow which is found in the ribs, the vertebrae, 
the sternum, the bones of the skull and as innominatum. 
·It is in the red marrow that granulopoesis takes place 
normally. The size of the granulopoietic organ in the 
adult has a volume of about 1,420 cc, which is thirteen 
times as great as that of the spleen and about the same 
as that of the liver. There are from three to twenty 
times as much tissue devoted to granulopoiesis as there 
is to erythropoiesis. The life span of the neutrophil 
is about four days after it reaches the blood stream. 
There are various physiological outflowings of the 
granulocytes from the blood into the tissues with 
consumption in the tissues. Neutrophils are eliminated 
into the saliva, the entire digestive tract, e.nd through 
all the mucous membranes. A gradual loss of granu-
lopoietic tissue ensues with advancing years. (7). 
The granulocytes have an hourly fluctuation. There is 
a reciprocal relationship between myelocytes and the 
mature neutrophiles. It is suggested, then, that this 
fluctuation is caused by withdrawal of the mature 
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neutrophiles from the peripheral circulation. (30). 
Besides this hourly fluctuation, there are two general 
tides of leucocytes. The tide is high in the early 
aft~rnoon and in the hours after midnight. This is 
largely due to the neutrophilic element and is not 
influenced by any factor of daily life. There is little 
individual variation in this process. The fluctuation 
is not confined to the periphery, but is generalized 
over the entire body. (111). Sabin showed rhythmic 
occurrence of young polymorphs in the periphery after 
occurrence of old non-motal neutrophiles. This may account 
for the occurrence of an hourly tide, probably by reflex 
stimulation. This further substantiated by the fact 
that the blood during these tides shows a neutrophilic 
shift to the left. ( 29). 
In neutropenia a cessation of the bone marrow supply 
of neutrophiles results in a peripheral shortage in about 
three to four days. This may proceed gradually until 
the total peripheral count is 1, 000 or less. At the 
beginning of the disease the granulocytes fall rapidly, . 
usually to 700 or 600 cmm. Thus the granulocyte shows 
30 to 40% of the total count in chronic cases to absolute 
absence in severe forms. In almost all cases their 
morphology is normal. However, it is found that the 
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motility, vitality, and phagocytic ability or the cells 
is decreased. It is interesting to note that besides 
the absent maturation factor which would plainly call 
forth these changes, there is, many times, a normal or 
hyperplastic gra~ulopoiesis which also suggests a 
chemotactic factor. ( 7) • 
Besides the change in neut rophiles there may be a 
small to great absolute decrease in the lymphocytes. 
This may be without evidence of destruction in the 
lymphatic tissues. A depression of the reticular 
endothelial system may cause a decrease in ntnnber of 
monocytes. To compensate for this the macrophages may 
be increased, and many times these and the clasmatocytes 
elaborate granules and seemingly take over the function 
of the granulocyte. 
The erythrocyte is usually not decreased except in 
chronic cases. Here the hemoglobin is also effected. 
Likewise, in long cases, the blood platelets may show a 
reduction. (7). In contradistinction to the latter 
statement, Danashek, in a review of many cases, states 
that thrombocytes are decreased only in the first two 
weeks. Most investigators hold that this is not true 
and that if a change in thrombocyt es is noted in the 
first two weeks, it is an increase rather than a 




It must be remembered that the drop in leucocytes 
occurs before the clinical onset is evident, and that 
the observer usually sees these changes at completion 
of his examination of the clinical case. (6). 
At the depth of the disease, a shi~ to the le~ of 
myelocytes can be observed. It has been suggested that 
there are not only young cells but abnormal young cells 
which might further suggest an abnormal chemotactic 
factor as well as the maturation factor. This phenomena 
is o:ften seen in cases with hyperplasia of the marrow.(38)· 
It is sometimes confusing to see the generality o:f 
this description confused by infection. Many times this 
changes the entire picture. Here if the observer will 
merely consider the effects of this process and the initial 
cells which it has to effect in the blood, he can 
interpret the changes. (65) 
The toxicity of the blood serum itself has been 
suggested by several observers. Beck mixed normal 
leucocytes with serum of a patient suffering from 
agranulocytosis. The leucocytes were seen to become 
rounded and lose their mortality in about 45 minutes.(7) 
It might be interesting here to consider a theory 
of antigen and its reactivity which has long been 
suggested. by clinical observers. Shiff found that by 
inje.cting benzene, an etiological factor of this disease, 
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intraperitoneally in animals, the reactivity of antigen 
was increased. Rush found that rabbits injected with 
this substance reduce lysin formation for sheep blood 
corpuscles and praecipitin for horse serum in the con-
ditioned rabbit. Simmonds and Jones found a reduction 
of lysins for dog corpuscles and for typhoid apsonin in 
cohditioned rabbits (114). Winternitz found same to be 
true for pneum.ococcus. (?). Hektoen repeated this work 
and stated that at high antibody production benzene has 
little effect on leucocytes and also that it lowered 
leucocytic activity. (49). 
This then points out that benzene may effect the 
white cells in another indirect way. 
In acute fulminating cases of idiopathic nature, 
the pathology is usually limited to the marrow of the 
long bones. Here is seen usually a hypoplastic granu-
lopoiesis. The erythroblastic elements are usually 
unaffected. (65). The bone marrow changes are the same 
in the living patient as in the necropsy specimen. This 
has been shown by sternal biopsys. (61). The bone marrow 
in fatal cases usually shows marked degeneration. The 
marrow shows patchy necrosis, with the myelooytes and 
neutrophiles absent, or nearly so. The megakaryocytes 
and no:nnoblasts are usually uneffected so that the 
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hypoplasia involves the granulocytes only. However, 
this is not always true since three distinct types have 
been noticed; in one, a maturation of myelocytes had 
ceased; in another type, there was myeloid aplasia; while 
a third type showed normal myeloid elements. (7). 
The myelocytes themselves are usually degenerative or 
necrotic. Some cells have deeply basophic and vacuolated 
cytoplasm with large pale staining nuclei. Some contain 
several nuclei. Rose and Houser saw hyalin drops in 
the cytoplasm with pale falloned or picnotic nuclei. 
Ven der Wielen describes cells with no granulation and 
small picnotic nuclei. Offenorde spoke of large cells 
with a pale cytoplasm and various forms of nuclear 
degeneration. Fried, Danashek, Naegele and Koch spoke 
of wide necrosis of the marrow. Koch added that the 
bone marrow was o~en deprived of granulopoietic elements 
but that lymphoblastic elements were greatly increased. 
The reticuloendothelial elements are o~en hypertrophic 
and show erythrophagocytosis and phagocytosis of iron 
pigment. Perchenbach's patient showed a fatty bone 
marrow with cellular areas composed chiefly of promyel-
ocytes. Fitz-Hugh and Krumbhaar found that many times 
the mature granulocytes are absent and that there is an 
abnormal nmnber of young neylocytes with pale nuclei 
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and many neutrophllic granules. Many times death may 
occur when'there is an abundance of these parental cells 
but a peripheral leucopenia. Here the maturation factor 
is de:ficient at work. Zekowsky believed that in hyper-
plastic marrows a bloch (chemotactic factor) existed. 
If this held for a period of time, degeneration would 
begin. Many cases at death show myeloid hyperplasia. 
Following are a few concrete examples of some of 
these cases: 
In three cases of idiopathic agranulocytosis the 
bone marrow was found to be much more cellular than the 
age of the patient would suggest. In this hyperplasia 
the granulopoietic tissue of the patient took an active 
part. It seems, tllerefore, that in some cases the 
agranulocytic catastrophe is preceded by a proliferation 
of the young myelocytes. In some cases, the cell content 
· of the bone marrow of the femur was not increased, and 
the destruction of the granulopoietic tissue did not 
follow an initial hyperplasia. In both the hyperplastic 
and the non-hyperplastic bone marrow, the granulopoietic 
cells revealed severe regressive changes, and it was 
often only by comparison with the less altered cells 
that the young myelocytes could be identified as such. 
Specific granulation is the first to become affected 
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while the nucleus remains intact for some time and may 
even divide by mitosis. Specific granules swell, their 
outlines become indistinct, and small vacuoles often 
appear around them. The granules later dissolve into 
these vacuoles and pale purple pink: droplets result, 
which fuse together, giving a vacuolated appearance to 
the cells. In the meantime, the chromatin o:f the nuclei 
has become separated into coarse, sharply defined clumps, 
and the nuclei have disappeared. An occasional mitosis 
may be detected in a cell which has been deprived of its 
granulation. The mitosis is, however, a typical with 
short and clumsy chromosomes and do not seem to pass 
beyond the metaphase. The nucleus finally shrinks and 
disappears; the cytoplasm coagulates and the cell dies. 
With the dissolution of the granules into the vacuoles 
the oxidase reaction becomes negative. When present, 
the myeloblasts appear intae.t which suggests that 
therapeutic attempts are not absolutely hopeless in the 
acute forms of the disease. 
The great majority of cases of agranulocytosis show 
histological evidences of a severe injury to the granu-
lopoiet ic tissue. 
In many cases, the giant .cells are increased in 
number and many young f'orm.s with signs o:f multiplication 
of the nuclei were present. Thus the megokaryocytes may 
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may be involved also. 
In cases of long standing granulopenia, a moderate 
anemia may develop. The norm.oblasts vary considerably 
in size, and some of them were large and hyperchronic. 
Segment at ion of the nucleus infrequently seen before 
picknosis is complete. 
Lymphocytes and plasma cells are always present (59(. 
The liver shows perivascular lymphocytic infiltration; 
Kupfer cells containing much pigment and Glisson's 
capsule is o~en overlain with a thin inflammatory 
exudate. (94). An increase in Kupfer's cells is o~en 
present. The liver cells themselves show cloudy swelling 
and small areas of necrosis. (?). 
The spleen often shows tremendous development of 
the reticular endothelial system at the expense of the 
lymphatic elements. The sinus are empty, with the 
exception of a few lymphocytes, plasma cells, and red 
blood corpuscles. The reticulum of the white pulp 
contains scattered lymph and plasma cells. Megakaryocytes 
are present. (94). The whole organ might be enlarged 
due to the reticuloendothelial hypertrophy. No young 
cells or lymphoblasts are seen in the atrophic lymph 
follicles, but only mature lymphocytes. Anemic infarcts 
are occasionaly seen. 
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The lymph nodes are sometimes enlarged with 
hemorrhages. Atrophy of follicles is present with no 
young lymphocytes in the germinal center. A prolif-
eration of reticular endothelial cells is also seen 
here. (?). 
In the kidney, in cases with sepsis, cloudy swelling 
bacterial embolin, marked degeneration of tubules and 
acute nephitis is seen. (94). 
Necrotic lesions of the mouth, anus and cervix show 
an absence of a surrounding inflammatory zone, no granu-
locytes being present. O~en edema and gangrene are seen. 
The gastro-intestinal tract may also present ulcerations. 
The lung shows sub-pleural hemorrhages with bacteria. 
Complications by generalized infection, toxic myocarditis, 
cloudy swelling, fatty degeneration and multiple areas 
of necrosis of' the liver may be encountered. ('65). These 
ulcerative sites are secondary to blood changes and due 
to lack of body resistance. (61). 
The pathological changes in septic forms has already 
been mentioned and shown how it might change and compli-
cate the picture both in hematological and local 
pathology. 
Changes due to radiation or to drug influence are 
essentially the same as described above. The differences 
are merely that the red elements and negakaryocytes seem 
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to be more prone to changes than in the idiopathic form. 
These changes are however, the same as those listed 
above as far as clinical facilities can be determined 
but tend to advance with the granulopenia rather than 
only in old chronic cases as it was described under in 
the above discertation. However, even here, granulopenia 
and effect on granulopoiesis is much more marked. 
These points are born out by experimental production 
on laboratory animals, and by accidental poisoning in 
clinical cases. (32), (90), (69), (88), (113). 
DIAGNOSIS .AND DIFFERENTIAL DIAGNOSIS 
This is usually rather simply made if one observes 
all of the material with which he has to work. Beck 
states that if one has the clinical picture, accompanied 
with a persistent ulcerative lesion, a study of the 
blood picture, with perhaps a sternal biopsy, will cinch 
tbe diagnosis. (?). A clinical syndrome might be de-
scribed as: (a) weakness, (b) easy exhaustion, (c) tendency 
to fatigue, {d) loss of strength and inertia, (e) a loss 
in the number of granulocytes. The severity of the 
disease almost parallels the degree of depletion of 
the bone marrow elements. 
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A few entities might be confused with this picture. 
Ludwig's angina differs in that the membrane of agranu-
locytosis is a tenacious gray membrane which does not 
bleed on removal. This also is easily ruled out by 
the blood picture. Some investigators class thorium., 
arsenic, benzol and x-ray as acute poisons with second-
ary granulopenia. Differential diagnosis is made here 
by history. X-ray also first attacks the lymphocytes 
and the granulocytes secondarily. Acute leukemia 
presents a high fever, a mucous membrane with petechial 
hemorrhages, enlarged nodes and spleen and a stomatidis 
with a leucocytosis. Sepsis also shows a leucocytosis. 
An aleukemic leukemia presents abnormal lymph forms, 
presence of polymorphonuclears and the same clinical 
picture as leukemia. (61) A lymphosarcoma may cause 
a leucopenia but may be differentiated by clinical 
course and biopsy findings. Aplastic anemia shows a 
reduction of all blood elements. Infectious mono-
nucleosis will show an increase in circula~ing neutrophiles 
upon the injection of foreign protein. 
THERAPY .AND PROGNOSIS 
Discussion of this phase of the subject will 
necessarily be laden with many procedures that have 
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been proven to be of little value. If the latter is 
true, indicatio~ will be given af'ter the discussion. 
Local lesions are present in the form of ulcers 
of the. various mucous membranes. The most important 
are found in the oral and pharyngeal cavities. These 
are primarily treated by cleanliness subsidized by 
application of antiseptic solutions. (65) A method of 
treatment can be outlined as follows: A saturated 
solution of potassium chlorate is sprayed on the 
cleansed lesion. The denuded area is then painted with 
a solution of ten grains of copper sulphate per ounce 
of water. The phlegm.onous masses are then excised and 
any abscesses are drained. It is well to mention here 
that surgical procedures should be avoided unless 
absolutely necessary since the lowered concentration of 
white blood cells make it a dangerous enterprise. (7) 
Nucleic acid and its derivatives were probably the 
most important development ever advised with the possible 
exception .of the yellow bone marrow extract recently 
advocated. Nucleotides were first advocated in 1897 
by .Ames, Delano and Huntley, as a treatment for 
leucopenia. They claimed a rise of the white blood 
cells in five to ten minutes af'ter injection of the 
·{Ilaterial in both the peripheral and central circulation. 
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They stated that the polymorphonuclears were little 
effected, but that many young mononuclears were present. 
In normal patients white blood count could be raised 
to 25,000 in forty-five minutes. (2). It is interesting 
to note that even before this experimental work was 
done in 1897, Vaughan, who had evidently noted some of 
its action upon patients, recommended its use in 1893 
as a germicide when given intravenously. (11?). The 
treatment was used intermittently in therapy of 
leucopenia with no advancement being made in either its 
use or its understanding until 1924 when Jackson 
isolated from human blood a substance which he believed 
to be adenine nucleotide. This was combined, or mixed, 
wlth an equal amount of pyramidine nucleotide. (56). 
In 1925 Jones and Perkins prepared B. Nucleoprotein and 
from this fonned crude nucleotides. They then separated 
guanine and adenine fractions and finally obtained the 
brucine salt from the pancreas. (60) In 1931 Reznikoff 
suggested the following treatment: Adenine sulphate 
injected at the rate of 0.5 grams in 25cc of normal 
saline per day. In six hours he noticed a rise in the 
white blood cells, the polymorphs appearing normal. 
He treated two cases ·this way and both recovered. {100) 
Dameshek, in a review of this work, stated that this 
tnerapy alone had lowered the mortality rate of 
5?. 
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granulopenia from 80-90% to 25%. He also published 
some of his own case work and gave three cases, all of 
the relapsing or recurrent type, which had recovered 
under use of these derivatives. To case I he gave 10 cc 
of pentnucleotide intramuscularly daily for four days. 
After 72 hours from the time the first injection was 
given, the white blood count began a gradual climb 
which ended five days later with a count of 16,800. 
It then gradually returned to normal, remaining thus. 
Case II was given adenine sulphate. One injection of 
0.5 grams of material caused definite improvement. The 
leucopenia recurred and was treated with pentnucleotide 
with essentially the same results as obtained in case I. 
His third case was also treated with pentnucleotides 
which showed definite improvement in 72 hours. (24) 
Fitz-Hugh injected 0.7 grams of the substance intra-
muscularly twice daily for four days. This caused 
definite improvement in two days after cessation of 
injection. Granulocytes were seen here for the first 
time in two weeks. (37). Marriott, in one instance, 
gave 2.8 grams ( of pentose nucleotide) intramuscularly, 
for ten days and then 0.7 grams via the same method for 
five days. Transfusions were also given along with calf 
liver. The patient recovered. (80) 
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Adenine sulphate usually produces a speedier improve-
ment in patients but also gives a more severe reaction, 
(i.e. chills, etc.) than does pentnucleotide. If the 
leucopenia is secondary to sepsis, aplastic anemia, or 
aleukemic leukemia, there will be no improvement. 
Following the administration of these drugs, there occurs 
a sharp dyspnoea, precordial distress, bradycardia, and 
sweating if it is given intravenously. The latter is not 
so marked if the drug is given intramuscularly. Follow-
ing injection these symptoms usually last for about one 
hour. The first change in the blood picture is histeo-
monocytosis followed by an increase in immature granu-
locyt es and a rise in the entire white blood count. 
The order of appearance of the granular cells is first 
myelocytes, metamyelocytes and finally mature neutrophiles. 
The white blood count rises about two days after the 
appearance of the immature cells. Clinical improvement 
which is coincident with quite a noticeable rise in the 
white blood elements, does not occur until five to seven 
days. The counts rise to 18,000 - 20,000, on the 
average, after ten days of treatment. Some investi-
gators found improvement in three or four days, a.fter 
injections were started, until clinical improvement was 
noticed. ( 24), ( 40). 
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From this it is seen that nucleii acid and its 
derivatives are primarily chemotactic. If maturation 
is absent, chemotaxis would be of little value; so it 
is not the utopia of therapy. (?). Chemically, nucleic 
acid yields, upon hydrolysis, phosphoric acid, a. sugar 
or a derivative of a sugar, basis of purine or 
pyramidine. The plant, nucleic acid, has an extra 
sugar (d-rebose), and animal nucleic acid has thymine 
and desorypentose. In the digestion of nucleic acid, 
it is found that neither the gastric nor pancreatic 
enzymes play much of a part. The succus entericus, 
however, contains a nucleinase that converts tetra-
nucleotides to mononucleotides. It also contains a 
nucleinase, n.ucleotidase, nucleosidase; so the end 
products as phosphoric acid, nucleosides, sugar, guanine 
and adenine go to the liver. These facts might be 
use1Ul as a factor in administrating these products 
orally or in administrating animal products rich in 
t etranucleotides. ( 44) 
A few experimental phases of this form of treatment 
might be mentioned. 'l'he induction of nucleinate on 
rabbits produces a primary leucopenia for several hours. 
This is followed by an increased delivery of new forms 
causing leucemia. Both are due to the granulocytes. 
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Bone m.arrow slides show a speeding up of later stages 
of granulocyte production. The primary leucopenia is 
caused mostly by the spleen since splenectomy shortens 
the primary leucopenia greatly. The spleen actually 
increases in size during the leucopenic period. Adenine 
and guanine sulphate cause no initial leucopenia. (29) 
When nucleic acid and its derivatives are injected intra-
venously with phosphate buffers, a short primary 
leucopenia is noted. This was not produced when normal 
saline solution was substituted for the buffer solution. 
The leucopenia was caused.by decrease in lymphocytes. 
Nucleoproteins also produce a leucopenia. (99) Climenko 
found that nucleic acid and its derivatives do not react 
when given a~er or with benzol derivatives. (22} 
Doan kept animals on nucleinate for 102 to 116 days with 
a constant hyperplasia of marrow but found no harm done 
to this organ a~er this length of time; so this therapy 
seems to be quite safe. (31) 
Transfusions have been used quite extensively with 
this disease but with very doubtful beneficial results. 
It is evident that frequent transfusions of a large 
enough quantity might serve in keeping a much distressed 
patient alive until some more potent form of' therapy may 
be tried. Fisher used immune serum. from a donor who 
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had recovered from granulopenia. Ordinary blood had 
previously been tried with negative results. After 
this transfusion the :patient seemed materially aided, 
and he recovered. ( 36) It seems that such a procedure 
would be rather trying, hov-.rever, since the donor was 
none too sure of not needing all of his own blood in 
a remission. 
Radiation of bones with X-ray seems to be definitely 
beneficial. The exact dose varies greatly with individ-
uals. One-twentieth of a skin unit might be satisfactory 
for one individual but quite insufficient for another. 
Too large a dose of this material is definitely danger-
ous, since the very disease one is trying to cure may 
be listed as being cau$ed by excessive X-ray as a 
etiological agent. Small doses should be administered 
first and only then by a competent roentgenologist.(7) 
Many clinical cases may be found which when this treat-
ment was used, had very definite improvement, both 
hematologically and clinically. 
Calcium gluconate has been reported as giving a 
granulocytic response five days after injections were 
started. (7). Orange juice, brewers yeast, bone marrow 
extract and cod liver oil have all been used with 
dubious results. Other miscellaneous items that have 
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been tried include milk, gentian violet, fetal liver, 
Squibb's leucocytic extract, Armour's extract of spleen, 
intravenous antistreptococcus serum, diphtheria anti-
toxin, non-specific proteins, etc., All of these 
produced little, if any, effect upon the patient, either 
clinically or hemotologi·cally. ( 65) 
One investigator used typhoid vaccine with a report 
of recovery. (6) Some cases show an "allergic state" 
in which they tremble, etc. This is especially mani-
fested at the onset of clinical symptoms. Adrenalin 
' 
seems to combat this state. ( 39). Massive doses of 
liver therapy, have been used with no definite results. 
In cases where symptomatic cardiac discomfort is 
developed colloidal sulphur seems to be of some value.(65) 
In cases produced by arsphenamine therapy, intravenous 
sodium theosulphate seems to present therapeutic 
advantages. The dosage suggested being O. 3 grams, 
increasing 0.15 grams daily until 2 grams have been given. 
Prophylactic treatment includes rest, cessation of all 
types of toxins, and a high vitamin ·B. diet. (?) 
There are three types of treatment that are rather 
late developments which have been left purposely to the 
last for discussion. For two of these there is no 
clinical data. The first of these substances is 
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glutathione. This is found normally in all body cells. 
In cases of benzol poisoning, it is reduced. In myloid 
leukemia, it is especially elevated and in leucopenia 
it is decreased. It was reasoned, therefore, that if 
this substance be given, an increase in division of 
myelocytes may be obtained. It is found that beneficial 
results are obtained in animals with benzol poisoning, 
a leucopenia being present in these same animals. In 
normal animals, however, no leucocytic response was 
gained. (92). 
Greer, in working with rats with experimental 
granulopenia resulting from benzol poisoning, intro-
duced another form of therapy. This was fetal calf 
spleen. In animals treated, a 25% mortality rate was 
established. In those untreated, 66% mortality rate 
was obtained. In his experiments he found fetal spleen 
nucleoprotein, raw fetal spleen and fetal spleen powder 
to be ascending in that order in benefit derived. 
Pentnucleotid also increased the white blood count, 
but a higher mortality rate was noted. Powdered beef 
spleen and fetal spleen cystosine groups were no better 
off than the control group. 
The third of this last group is a development of 
the last year which gives more promise than any treatment 
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developed to date. This is extract of yellow bone 
marrow introduced byMarberg and Wiles in 1938. Yellow 
bone marrow was saponified with an excess of potassitnn 
hydroxide. The unsaponif'iable portion was then extracted 
in vacuum. This portion was found to contain almost all 
of the active ingredient by clinical tests. The oil 
extracted was then absorbed in some bland oil, such as 
cotton seed oil, so that 0.05 cc contained 2 grams of 
the strained yellow bone marrow. Of the normal persons 
tested only one responded. The blood count in this 
instance (after one teaspoonful taken orally of the 
concentrate) was raised from ?,000 to 21,000 in twenty 
four hours. One case was given 10 drops three times 
daily for two days followed by half that dosage. The 
white blood picture went from 2,600 to 5,400 and the 
polymorphonuclears from 2?% to 35% in nine days. Another 
patient had been on pentnucleotides but the treatment 
was considered unsatisfactory. With the blood count at 
4,500, the patient was given 105 drops of oil per day. 
In four days the count was up to 7, 500. The treatment 
was discontinued and the count dropped to 3,500 in four 
days. Then starting with 65 drops per day, it resulted 
in a count of 7,500 in five days. Of seventeen cases 
treated, almost all of whom had been treated unsuccess-
fully with other known forms of treatment, mostly 
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nucleotides, ten recovered and seven died. Of the 
seven who died, three had aplastic anemia and one had 
diabetes. Of the ten who recovered, six had agranu-
locytic angina and four had leucopenia without angina. 
The response was both clinical and hematological in 
forty-eight hours. The authors state that clinical 
recovery followed immediately the return of the blood 
picture to the phase expected by the local lesions. ( 79) 
The prognosis has been discussed with the types 
of treatment. Here may be given a few generalities. 
The prognosis depends upon the severity of the neutro-
penia. Rosenthal states that a white blood below 1000 
cells per cm. gives a poor prognosis, while one over 
1,000 gives a good prognosis. It must never be for-
gotten, however, that the individual might die from a 
subsequent attack. (66). A mononucleosis developing 
in the course of treatment is a favorable sign. (100) 
"When the disease was first described, the prognosis 
was practically 100% mortality. In 1927 it was still 
90 - 95%. In 1931 it dropped to 50%, and at the present 
time is only 25%. From this, it is seen that treatment 




DI SCTJSSION AND SUMI\11.ARY 
From the body and discussion of the subject, one 
can see that there are still contraversial points. 
Most of these are not, however, antagonistic points of 
a true nature but merely isolated facts about which the 
intermediate is still obscure or not yet worked out. 
The history of the disease reveals the fact that 
while the recognition of the syndrome itself is only 
seventeen years of age, the picture has been described, 
sometimes quite completely, all through this century 
and had been suggested in the fifty years preceding 
1900. In the last ten years knowledge has become widely 
distributed, and the disease is being recognized with 
more and more frequency. Aside from this, the actual 
incidence seems to be growing since men who have been 
recognizing the syndrome for a number of years advance 
the opinion that it has, of late years, been more 
prevalent. Perhaps this is due to the cumulative effect 
of etiological agents such as benzene ring derivatives. 
The etiological agents may be divided into four general 
classes; (a} Agranulocytosis: The idiopathic form of 
the disease which shows perhaps the most truly typical 
form of the syndrome. {b} Agranulosepsis, which is 
caused by bacteria or their products. It is probably 
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more true to say just the products since, on normal 
animals, bacteria produce the typical septic picture, 
and only the products when injected will produce the 
entity similiar to the clinical phase of agranulocytosis. 
There is also no evidence to show that bacterial 
septicemias, when found in these cases, are not really 
secondary. In fact, evidences of the bacteremia have 
never been demonstrated before the clinical onset of 
the complex. ( c} Agranuloradiation is that form of the 
entity developed when excessive X-ray, radium products 
or any radioactive substance has been ingested to any 
marked degree. This form of granulopenia is prone to 
be accompanied by anemia and effects on the erythro-
plastio portions of the bone marrow; so many authors 
consider it as more truly classed in the realm of 
aplastic anemias. ( d} Agranulotoxicosis is that portion 
of the syndrome caused by toxic substances such as 
benzene and its derivatives. Small doses of these 
substances over periods of time seem to produce the 
typical picture. Larger doses, however, seem to cause 
a condition more congruent with complete aplasia of 
the bone marrow. Several investigators believe that in 
nearly every case of agranulocytosis a history of one 
of these toxins can be gained. If this is true, the 
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class of idiopathic agranulocytosis is being almost 
eradicated. In a review of the literature it is 
apparent that many people can and do take tremendous 
quantities of these drugs without ill effects upon the 
hemopoietic system. There is, then, undoubtedly a 
factor of inherent weakness of t11is system. As long as 
this is true, it is not justified in ruling out com-
pletely, at least, agranulocytic angina idiopathica. 
The clinical onset is rapid and follows a hema-
tological onset of days to weeks or even months. The 
point of onset as relative to the blood picture is 
variable but is usually after the white blood picture 
showed fifty percent of its original concentration and 
one half of its customary granulocytic element. The 
severity of the symptoms are usually parallel with the 
severity of the hemotological deviation. The onset is 
marked with weakness, malaise, lassitude, inertia, etc. 
This is followed by sore mouth and subsequent fonnation 
of ulcerative lesions in these localities. The physician 
usually finds the patient well advanced in the disease. 
The clinical types may be divided into acute fulminating, 
with a high mortality; chronic with a low mortality; 
acute and chronic recurring, with corresponding mortality 
rates; cyclic variety which is regular, periodic; and 
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of either the acute or chronic variety with various 
gradations of these general classes. Recovery is rapid 
or gradual, depending on the etiology (whether or not 
it can be removed), the severeness of the disease, the 
condition of the patient, etc. Death, the other alt er-
native is likewise based on the severity, advancement 
and etiology of the syndrome. Chronic patients may show 
only one sign, that of weakness, for years on end. 
The pathology of the local lesion is a non-infil-
trat ed, denuded, inflamed area. That of the blood is 
a decrease to total lack of granulocytes with a total 
decrease of the white blood cells. The bone marrow 
shows a corresponding loss of granulopoietic elements 
to a complete aplasia of these factors. There may or 
may not be an associated decrease in the other elements 
of the blood. Some investigators would argue the 
associability of this as contiguous with the syndrome, 
but when one considers the common origination of all 
blood cells, one can readily realize that these related 
elements may become affected merely as a matter of course 
in the disease itself. Could one not, therefore, consider 
this entity as a step in one of the processes of 
production of aplastic anemia? .And if this is true, 
why would not benzol and its derivatives be a true, or 
?O. 
partial, etiological factor since the degree of benzol 
poisoning seems to determine just what type arid how many 
of the cellular elements of the marrow and blood are 
affected. Likewise, the spleen and nodes, or the lymph-
atic elements, often show atrophic processes. Experi-
mental evidence indicates that many of these points are 
true. 
Treatment of this disease entity has progressed 
rather rapidly. The value of nucleic acid and its 
derivatives had been known even before the syndrome 
itself was described. Its application has done much in 
offering a better prognosis. Its value is chiefly 
chemotactic in nature. Glutathione offers a possible 
addition in that it might supply the maturation factor. 
Both of these factors are supplied with both fetal calf 
spleen and yellow bone marrow extract with the latter 
being much more successful as far as can now be 
determined. Radiation of the long bones seems to be 
stimulatory, but the danger of its use and its inaccess-
ability place it in a less desirable group. Transfusions 
are helpful only as a direct treatment to prolong life 
until another form of treatment has time to exert its 
influence. Actual stimulation from blood transfusions 
in recovered cases has been reported as beneficial, 
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but its possible reaction on the donor makes it.s use · 
of doubtful value from a practical standpoint. Other 
forms of treatment with the exception of local ulcer 
treatment are of doubtful value. 
Diagnosis is made upon the clinical symptoms, com-
bined with the blood picture. All other forms can be 
ruled out by using these two phases, but all other 
diseases can not be ruled out by using only one of them. 
For example, the blood picture of aleukemic leukemia 
has been confused with that of this syndrome, and some 
leukemias with oral sepsis may closely simulate this 
disease clinically. 
Agranulocytic angina may be rather simply and 
accurately diagnosed and may usually be treated success-
fully as demonstrated by the fall in mortality. It is, 
therefore, a disease in which medical science from an 
experimental and clinical angle, should be congratulated. 
Yet, much remains to be gathered about its intricate 
mechanisms, and even greater success should be procured 





1. Agranulocytosis is a disease of recent recognition 
but of probably much older history. 
2. Its etiology may be divided into idiopathic agranu-
locytosis, agranulosepsis, agranulotoxicosis, end 
agranuloradiation. 
3. Its clinical course is characterized by weakness, 
prostration, inertia, formation of mucous membrane 
ulcers and a low white blood count with a granulopenia. 
4. Pathological changes in the bone marrow may be either 
conducive with the clinical blood picture which shows 
an abnormal maturation factor: or the marrow might 
be norm.al or hyperplastic, showing abnormal chemo-
tactic factor. 
5. Diagnosis is made upon clinical symptoms with the 
help of the blood picture and perhaps sternal biopsys. 
6. Treatment is successful in so far as the prognosis 
has been considerably improved. The successful 
forms of treatment, besides the local management of 
ulcers are; Irradation of bones - stimulative but 
dangerous in as much as aplasia may be instigated; 
Nucleic acid and its derivatives - chemotactic; 
Glutathione - maturative; Foetal spleen - both 
chemotactic and maturative, and yellow bone marrow 
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extract, both maturative and chemotact ic and of 
greater potency than any of the others. 
7. Prognosis has improved from 100% mortality to 25% 
in the last fifteen years. The prognosis varies 
almost directly with the abnormality of the blood 
picture and the severity of the attack. 
74. 
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